[
    {
        "file_name": "RevolutionMedicinesInc_20200117_S-1_EX-10.1_11948417_EX-10.1_DevelopmentAgreement.txt",
        "perturbation": [
            {
                "type": "Structural Flaws - Legal Contradiction",
                "original_text": "13.3 Covenants by RevMed. RevMed covenants to Sanofi that:\n\n(a) RevMed will not, and will cause its Affiliates not to, grant a lien on the RevMed Licensed Technology to any Third Party or knowingly permit a lien to be imposed on the RevMed Licensed Technology other than those disclosed to Sanofi by RevMed and that do not conflict with the rights granted Sanofi hereunder.\n\n(b) RevMed will not, and will cause its Affiliates and (sub)contractors not to, use any government or not-for-profit organization funding that would encumber the RevMed Licensed Technology without the prior written consent of Sanofi, which consent may be withheld in Sanofi's sole discretion. For clarity, this Section 13.3(b) does not apply to Permitted Contractors and Researchers.",
                "changed_text": "13.3 Covenants by RevMed. RevMed covenants to Sanofi that:\n\n(a) RevMed will not, and will cause its Affiliates not to, grant a lien on the RevMed Licensed Technology to any Third Party or knowingly permit a lien to be imposed on the RevMed Licensed Technology other than those disclosed to Sanofi by RevMed and that do not conflict with the rights granted Sanofi hereunder.\n\n15.18 Further Actions. Each Party agrees to execute, acknowledge and deliver such further instruments, and to do all such other acts, as necessary or appropriate in order to carry out the purposes and intent of this Agreement.\n\n(b) RevMed will not, and will cause its Affiliates and (sub)contractors not to, use any government or not-for-profit organization funding that would encumber the RevMed Licensed Technology without the prior written consent of Sanofi, which consent may be withheld in Sanofi's sole discretion. For clarity, this Section 13.3(b) does not apply to Permitted Contractors and Researchers.",
                "explanation": "Moving covenant (b) to be within the 'Further Actions' section weakens its legal impact because covenant are related with obligations under the contract, which makes it more difficult to enforce as a direct promise from RevMed.",
                "contradicted_law": "General contract law, specific performance of covenants.",
                "location": "Section 13.3"
            },
            {
                "type": "Structural Flaws - Legal Contradiction",
                "original_text": "13.6 Closing Conditions. The obligations of each Party to consummate the transactions contemplated by this Agreement and the Ancillary Agreements (the \"Contemplated Transactions\") is subject to the fulfillment, or, to the extent permitted by Applicable Law, waiver by such Party, of each of the following conditions (collectively, the \"Closing Conditions\"):\n\n(a) The representations and warranties of the other Party contained in this Agreement (i) that are not qualified by materiality, material adverse effect, substantial compliance or similar materiality qualifier will be true and correct in all material respects both when made and at the closing with the same force and effect as if made on the Effective Date and (ii) that are qualified by materiality, material adverse effect, substantial compliance or similar materiality qualifier will be true and correct in all respects both when made and at the closing with the same force and effect as if made on the Effective Date, except, in each of (i) and (ii) as would not reasonably be expected, individually or in the aggregate, to have a material impact on the transaction contemplated by this Agreement.\n\n(b) All actions by (including any authorization, consent or approval) in respect of (including notice to), or filings with, any Governmental Authority or other Person that are required to be obtained pursuant to Section 3.8 to consummate the Contemplated Transactions (including any HSR/Antitrust Filing) will have been obtained or made, in a manner reasonably satisfactory in form and substance to such Party, and no such authorization, consent or approval will have been revoked.\n\n(c) No Material Adverse Event shall have occurred or arisen since the Execution Date.",
                "changed_text": "13.6 Closing Conditions. The obligations of each Party to consummate the transactions contemplated by this Agreement and the Ancillary Agreements (the \"Contemplated Transactions\") is subject to the fulfillment, or, to the extent permitted by Applicable Law, waiver by such Party, of **some** of the following conditions (collectively, the \"Closing Conditions\"):\n\n(a) The representations and warranties of the other Party contained in this Agreement (i) that are not qualified by materiality, material adverse effect, substantial compliance or similar materiality qualifier will be true and correct in all material respects both when made and at the closing with the same force and effect as if made on the Effective Date and (ii) that are qualified by materiality, material adverse effect, substantial compliance or similar materiality qualifier will be true and correct in all respects both when made and at the closing with the same force and effect as if made on the Effective Date, except, in each of (i) and (ii) as would not reasonably be expected, individually or in the aggregate, to have a material impact on the transaction contemplated by this Agreement.\n\n(b) All actions by (including any authorization, consent or approval) in respect of (including notice to), or filings with, any Governmental Authority or other Person that are required to be obtained pursuant to Section 3.8 to consummate the Contemplated Transactions (including any HSR/Antitrust Filing) will have been obtained or made, in a manner reasonably satisfactory in form and substance to such Party, and no such authorization, consent or approval will have been revoked.\n\n15.17 Translations. This Agreement is in the English language only, which language shall be controlling in all respects, and all versions hereof in any other language shall be for accommodation only and shall not be binding upon the Parties. All communications and notices to be made or given pursuant to this Agreement, and any dispute proceeding related to or arising hereunder, shall be in the English language. If there is a discrepancy between any translation of this Agreement and this Agreement, this Agreement shall prevail.\n\n(c) No Material Adverse Event shall have occurred or arisen since the Execution Date.",
                "explanation": "Closing conditions, it is moved such condition to the next section. Also, one has to be explicit in how all conditions must be valid/true; by mentioning just 'some', makes a legal issue arise since it's not made clear what condition(s) are needed for valid closing.",
                "contradicted_law": "General Contract Law, conditions precedent.",
                "location": "Section 13.6"
            },
            {
                "type": "Structural Flaws - Legal Contradiction",
                "original_text": "15.5 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without reference to any rules of conflict of laws.",
                "changed_text": "15.5 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, but **taking** reference to any rules of conflict of laws.",
                "explanation": "Governing Law. When not having rules to determine what has the most impact when determining if one of the two states has conflict laws, makes the law to be used less clear and enforceable. ",
                "contradicted_law": "General Contract Law, choice of law provisions.",
                "location": "Section 15.5"
            }
        ]
    }
]